Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines
- PMID: 24589970
- PMCID: PMC4130255
- DOI: 10.4161/hv.27264
Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines
Abstract
Haemophilus influenzae type b (Hib) and 7-valent pneumococcal (PCV7) vaccines both became recommended in Japan in 2010. In this study, cytokine production was investigated in peripheral blood mononuclear cells (PBMCs) cultures stimulated with diphtheria and tetanus toxoids combined with acellular pertussis vaccine (DPT), Hib, and PCV7 separately or concurrent different combinations, all as final off-the-shelf vaccines without the individual vaccine components as controls. Higher IL-1β levels were produced when cultures were stimulated with PCV than with DPT or Hib, and the concurrent stimulation including PCV7 enhanced the production of IL-1β. Although Hib induced higher levels of IL-6, no significant difference was observed in IL-6 production with the concurrent stimulation. The concurrent stimulation with Hib/PCV7 and DPT/Hib/PCV7 produced higher levels of TNF-α and human G-CSF. Cytokine profiles were examined in serum samples obtained from 61 vaccine recipients with febrile reactions and 18 recipients without febrile illness within 24 h of vaccination. No significant difference was observed in cytokine levels of IL-1β, IL-4, IL-6, IL-10, IL-12, IFN-γ, MIP-1, TNF-α, and prostaglandin E2 (PGE2) in sera between the two groups. However, significantly higher levels of human G-CSF were observed in recipients with febrile illness than in those without febrile reactions. Further investigations of the significance of elevated serum G-CSF levels are required in vaccine recipients with febrile illness.
Keywords: 7-valent pneumococcal conjugated vaccine; DPT; Diphtheria and tetanus toxoids combined with acellular pertussis vaccine; Haemophilus influenzaetype b T-conjugated vaccine; Hib; PBMCs; PCV7; cytokine; innate immunity; peripheral blood mononuclear cells.
Figures



Similar articles
-
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20. Pediatr Infect Dis J. 2014. PMID: 24346596 Clinical Trial.
-
Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.Hum Vaccin. 2011 Feb;7(2):258-64. doi: 10.4161/hv.7.2.14170. Epub 2011 Feb 1. Hum Vaccin. 2011. PMID: 21307655 Clinical Trial.
-
Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type B vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age.Clin Vaccine Immunol. 2010 Mar;17(3):311-6. doi: 10.1128/CVI.00315-09. Epub 2009 Dec 30. Clin Vaccine Immunol. 2010. PMID: 20042517 Free PMC article.
-
Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Pediatr Infect Dis J. 2009. PMID: 19325452 Review.
-
Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.Vaccine. 2018 Feb 8;36(7):986-996. doi: 10.1016/j.vaccine.2018.01.005. Epub 2018 Jan 12. Vaccine. 2018. PMID: 29336924 Review.
Cited by
-
Vaccines and sudden infant death: An analysis of the VAERS database 1990-2019 and review of the medical literature.Toxicol Rep. 2021 Jun 24;8:1324-1335. doi: 10.1016/j.toxrep.2021.06.020. eCollection 2021. Toxicol Rep. 2021. PMID: 34258234 Free PMC article.
-
Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice.Vaccines (Basel). 2022 Aug 18;10(8):1339. doi: 10.3390/vaccines10081339. Vaccines (Basel). 2022. PMID: 36016227 Free PMC article.
-
Cumulative inactivated vaccine exposure and allergy development among children: a birth cohort from Japan.Environ Health Prev Med. 2020 Jul 7;25(1):27. doi: 10.1186/s12199-020-00864-7. Environ Health Prev Med. 2020. PMID: 32635895 Free PMC article.
-
Cytokine and Chemokine Production in Mice Inoculated with NVX-CoV2373 (Nuvaxovid®) in Comparison with Omicron BA.4/5 Bivalent BNT162b2 (Comirnaty®).Vaccines (Basel). 2023 Nov 2;11(11):1677. doi: 10.3390/vaccines11111677. Vaccines (Basel). 2023. PMID: 38006009 Free PMC article.
-
COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.Front Immunol. 2022 Sep 2;13:975363. doi: 10.3389/fimmu.2022.975363. eCollection 2022. Front Immunol. 2022. PMID: 36119092 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) Global routine vaccination coverage, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1520–2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical